Alfuzosin Versus Placebo in Acute Urinary Retention (ALF-RIK)
The primary objective of the study is to investigate if 14 days of treatment with Alfuzosin compared to placebo, will increase the number of patients with satisfying spontaneous voiding after acute urinary retention treated with Clean Self-Catheterization.
Furthermore is investigated the safety of the medical treatment and self-catheterization.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Does Alfuzosin OD vs. Placebo in Male Patients Facilitate Spontaneous Voiding During Clean Intermittent Self-Catheterization Following Acute Urinary Retention?|
- Number of patients with satisfying spontaneous voiding after 14 days measured by bladder scan at day 14.
- Number of days until termination of self catheterization
- Number of patients with urinary infection requiring treatment
- Pressure of voiding, volume of voiding, residual urine after voiding, measured by urine culture and bladder scan at day 14.
|Study Start Date:||May 2004|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00453908
|Study Director:||Henning Andersen, MD||Sanofi|